We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The EPIC-XS Consortium Kicks Off

Article   Jun 14, 2019 | By Juan Antonio Vizcaino (EMBL-EBI, UK) and Julia Chamot-Rooke (Institut Pasteur, France)

 
The EPIC-XS Consortium Kicks Off

EPIC-XS consortium members who attended the kick-off meeting in Amsterdam, from left to right: Javier Munoz, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; Marteen Altelaar, Utrecht University, The Netherlands; Tiziana Bonaldi, Inistituto Europeo di Oncologia, Milan, Italy, and Kris Gevaert, Vlaams Instituut voor Biotechnologie, Ghent.

 
 
 

RELATED ARTICLES

Proteomics Up Close: An Interview With Dr Oliver Rinner

Article

We recently spoke with Dr Oliver Rinner, CEO at Biognosys, to learn more about the newest developments within the proteomics.

READ MORE

Proteomics Is Ready for Primetime

Article

The field of proteomics has advanced considerably over the past decade. Advances in technology such as mass spectrometry have allowed the field to overcome many analytical challenges, making it a promising approach for clinical applications.

READ MORE

Uncovering the Secrets of the Breast Cancer Epigenome

Article

The epigenome plays a crucial role in the development of breast cancer. This exciting and rapidly evolving area of research holds great promise for new interventions – from prevention through to personalized treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE